Sodium nitroprusside (SNP) is a water-soluble iron nitrosyl complex clinically used as a powerful vasodilator for treatment of hypertension; and, in basic research, it has been used to mainly investigate the cytotoxic effects of nitrosative stress. Although NO is considered a pharmacologically active molecule, not all of the biological effects of SNP are dependent on its NO moiety. To elucidate the molecular executioner(s) responsible for SNP cytotoxicity, this study determines the involvement of oxidative stress in p53 activation and apoptotic induction elicited by SNP in SH-SY5Y neuroblastoma cells. We demonstrate that proapoptotic activity of SNP is independent of NO production, because SNP and its 2-day light-exhausted compound SNP ex trigger apoptosis to the same extent. We provide evidence for the occurrence of oxidative stress and oxidative damage during both SNP and SNP ex exposure and demonstrate that iron-derived reactive oxygen species (ROS) are the genuine mediators of their cytotoxicity. We show that p53 is equally activated upon both SNP and SNP ex treatments. Moreover, as demonstrated by small interfering RNA experiments, we indicate its primary role in the induction of apoptosis, suggesting the ineffectiveness of NO in its engagement. The attenuation of p53 levels, obtained by oxy-radical scavengers, is consistent with the recovery of cell viability and ROS decrease, demonstrate that SNP-mediated p53 activation is an event triggered by ROS and/or ROS-mediated damages. Together, our results suggest that investigations of the physiopathological effects of SNP should consider the role of ROS, other than NO, particularly in some conditions such as apoptotic induction and p53 activation.NO is a diffusible and reactive free radical involved in a wide range of physiological functions, including the control of vascular tone, platelet aggregation, and the immune response (Moncada et al., 1991;Mannick, 2006). In the central nervous system, NO plays a pivotal role as neurotransmitter, neuromodulator, and neuroprotector, even if alteration in its synthesis is detrimental for neuronal cell viability. In fact, during its overproduction, NO acts as a proapoptotic molecule, activating mainly the mitochondrial apoptotic pathway by modulating the expression of apoptosis-associated proteins such as Bax and Bcl-2 (Brü ne, 2005;Pacher et al., 2007). Moreover, sustained production of NO and its reactive nitrogen species (RNS) leads to DNA damage, promoting the activation of the tumor suppressor p53 protein, which in turn can activate transcription of regulatory genes, allowing DNA repair, or programmed cell death (Brü ne and Schneiderhan, 2003;Vousden and Lane, 2007).In general, pathophysiological processes controlled by NO and RNS are investigated by using NO donors with different half-lives, chemical properties, and kinetics of release. One of the most known NO-releasing drugs is the nitroferricyanide